First Randomized, Double-Blind, Placebo-Controlled Study to Show Telomeres Getting Longer in Humans

Share Article

This new study, utilizing T.A. Science’s TA-65MD®, shows compelling scientific evidence in its ability to activate telomerase and lengthen telomeres.

News Image
This new study, published in Rejuvenation Research, confirms previous scientific studies demonstrating that TA-65MD® activates telomerase and lengthens telomeres in a statistically significant manner.

A new study, conducted on 97 relatively healthy cytomegalovirus-positive subjects aged 53-87, found participants taking TA-65MD® significantly increased telomere length over a 12 month period compared to a placebo group.

TA-65® is a patented, all natural, plant-based compound that animal and in vitro studies have indicated activates telomerase, which may help maintain or rebuild parts of the chromosomes, called telomeres, that diminish as people get older.

Telomeres protect the chromosome, preventing the loss of DNA to ensure cells replicate properly. As people age, telomeres shorten and leave the genetic DNA on the chromosomes vulnerable to damage and mutations. Over time, telomere shortening causes cells to die or to become senescent. By activating telomerase, an enzyme that adds nucleotides to telomeres, cells are able to live longer and continue to function properly.

This new study, published in Rejuvenation Research, confirms previous scientific studies demonstrating that TA-65MD® activates telomerase and lengthens telomeres in a statistically significant manner. Notably, this is the first double blind, placebo-controlled study to show actual lengthening of telomeres in humans.

“By activating telomerase, we can help slow and perhaps even reverse cellular aging. These findings are an exciting step in our goal to safely prolong the life of human cells,” said Noel Thomas Patton, the founder of T.A. Sciences, “We have been a leader in telomerase research since 2002 and will continue to invest in valuable research to help further the field of telomere biology.”

Study Summary:

  • Study participants: 97 men and women (53-87 years old)
  • Study length: 12 months
  • First study to show statistically significant (p<0.005) lengthening of telomeres in humans:

        - Placebo Group – Decrease in median telomere length over 12 month
Median telomere length: ↓ 290 ± 100 bp
20th percentile telomere length: ↓ 170 ± 50 bp
        - TA-65MD® Group – Increase vs placebo group in median telomere length over 12 months
Median telomere length: ↑ 533 ± 180 bp
20th percentile telomere length: ↑ 270 ± 90 bp

About T.A. Sciences®: Founded in 2002, T.A. Sciences® is the first healthcare company dedicated to creating research-based wellness products that help address cellular aging through Telomerase Activation. Built upon a foundation strongly grounded in scientific evidence, T.A. Sciences® is widely recognized as the leader in the field of Telomere Biology. TA-65MD® is available from licensed healthcare practitioners worldwide. For more information about T.A. Sciences®, visit http://www.tasciences.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jim Cich, President
Visit website